Request Demo
Last update 28 Jan 2026
Gemigliptin L-tartrate Sesquihydrate/Glimepiride
Last update 28 Jan 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Gemigliptin/glimepiride, Glimepiride/gemigliptin, ZemiSU |
Action inhibitors, blockers, modulators |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), KATP channels blockers, SUR modulators(Sulfonylurea receptor modulators) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC22H27F8N5O9 |
InChIKeyVAUAVIVJAZEKKT-ACTDTYNJSA-N |
CAS Registry1375415-82-9 |
View All Structures (2)
Related
1
Clinical Trials associated with Gemigliptin L-tartrate Sesquihydrate/GlimepirideNCT02089126
A Multicenter, Randomized, Placebo-controlled, Parallel Group, Double-blind, Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride Alone
100 Clinical Results associated with Gemigliptin L-tartrate Sesquihydrate/Glimepiride
Login to view more data
100 Translational Medicine associated with Gemigliptin L-tartrate Sesquihydrate/Glimepiride
Login to view more data
100 Patents (Medical) associated with Gemigliptin L-tartrate Sesquihydrate/Glimepiride
Login to view more data
100 Deals associated with Gemigliptin L-tartrate Sesquihydrate/Glimepiride
Login to view more data
R&D Status
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free